Swiss National Bank - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 193 filers reported holding DENALI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,967,704
-29.3%
240,800
+1.1%
0.00%
-20.0%
Q2 2023$7,026,331
+48.6%
238,100
+16.0%
0.01%
+66.7%
Q1 2023$4,727,808
-18.5%
205,200
-1.6%
0.00%
-25.0%
Q4 2022$5,798,385
-7.4%
208,500
+2.2%
0.00%0.0%
Q3 2022$6,264,000
+5.7%
204,100
+1.3%
0.00%0.0%
Q2 2022$5,927,000
-1.8%
201,400
+7.3%
0.00%
+33.3%
Q1 2022$6,038,000
-22.1%
187,700
+8.1%
0.00%
-40.0%
Q4 2021$7,747,000
-11.8%
173,700
-0.2%
0.01%
-16.7%
Q3 2021$8,783,000
-34.8%
174,100
+1.3%
0.01%
-25.0%
Q2 2021$13,476,000
+32.5%
171,800
-3.5%
0.01%
+14.3%
Q1 2021$10,170,000
-30.5%
178,100
+1.9%
0.01%
-30.0%
Q4 2020$14,641,000
+127.5%
174,800
-2.7%
0.01%
+100.0%
Q3 2020$6,435,000
+50.8%
179,600
+1.8%
0.01%
+25.0%
Q2 2020$4,268,000
+101.3%
176,500
+45.7%
0.00%
+100.0%
Q1 2020$2,120,000
+2.0%
121,100
+1.5%
0.00%0.0%
Q4 2019$2,078,000
+16.6%
119,300
+2.6%
0.00%0.0%
Q3 2019$1,782,000
-25.2%
116,300
+1.3%
0.00%
-33.3%
Q2 2019$2,383,000
-8.8%
114,800
+2.0%
0.00%0.0%
Q1 2019$2,612,000
+16.0%
112,500
+3.2%
0.00%0.0%
Q4 2018$2,252,000
-3.3%
109,000
+1.8%
0.00%0.0%
Q3 2018$2,328,000
+363.7%
107,100
+225.5%
0.00%
+200.0%
Q2 2018$502,00032,9000.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$339,037,00035.95%
Euclidean Capital LLC 323,749$27,117,0005.74%
Flagship Pioneering Inc. 2,730,263$228,687,0004.16%
Casdin Capital, LLC 1,310,000$109,726,0003.25%
A.R.T. Advisors, LLC 6,173$517,0002.39%
MARK ASSET MANAGEMENT LP 172,040$14,410,0001.73%
Temasek Holdings (Private) Ltd 4,410,457$369,420,0001.59%
Integral Health Asset Management, LLC 57,500$4,816,0001.43%
GILDER GAGNON HOWE & CO LLC 3,219,843$269,694,0001.34%
IRONWOOD INVESTMENT MANAGEMENT LLC 19,365$1,622,0000.95%
View complete list of DENALI THERAPEUTICS INC shareholders